nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Chronic Myelomonocytic Leukemia: 2018 Update to Prognosis and Treatment
|
Elmariah, Hany |
|
2019 |
14 |
3 |
p. 154-163 |
artikel |
2 |
Disparities in Survival and Health Outcomes in Childhood Leukemia
|
Winestone, Lena E. |
|
2019 |
14 |
3 |
p. 179-186 |
artikel |
3 |
Expert Panel Consensus Statement for Proper Evaluation of First Relapse in Multiple Myeloma
|
Offidani, M. |
|
2019 |
14 |
3 |
p. 187-196 |
artikel |
4 |
Integrative Approaches to Managing Myeloproliferative Neoplasms: the Role of Nutrition, Exercise, and Psychological Interventions
|
Surapaneni, Prathibha |
|
2019 |
14 |
3 |
p. 164-170 |
artikel |
5 |
Key Role of Inflammation in Myeloproliferative Neoplasms: Instigator of Disease Initiation, Progression. and Symptoms
|
Mendez Luque, Laura F. |
|
2019 |
14 |
3 |
p. 145-153 |
artikel |
6 |
Next-Generation Sequencing in Myeloproliferative Neoplasms: Is This Indicated in All Patients?
|
Mina, Alain Antoine |
|
2019 |
14 |
3 |
p. 137-144 |
artikel |
7 |
Targeting BTK in CLL: Beyond Ibrutinib
|
Bond, David A. |
|
2019 |
14 |
3 |
p. 197-205 |
artikel |
8 |
Trends in Clinical Benefits and Costs of Novel Therapeutics in AML: at What Price Does Progress Come?
|
Vaughn, Jennifer E. |
|
2019 |
14 |
3 |
p. 171-178 |
artikel |